Prof Ken Walder

STAFF PROFILE

Position

Chair In Metabolic Diseases

Faculty

Faculty of Health

Department

School of Medicine

Campus

Geelong Waurn Ponds Campus

Qualifications

Doctor of Philosophy, Deakin University, 1998

Contact

ken.walder@deakin.edu.au
+61 3 522 72883

Biography

Professor Walder is the Chair of Metabolic Diseases in the School of Medicine and the Molecular and Medical Research SRC. His research focuses on obesity and type 2 diabetes, and mental health disorders, and in particular the discovery of novel treatments for these diseases. After spending 2 years at the National Institutes of Health in Phoenix, Arizona, Professor Walder returned to Deakin University where he has played a key role in the evolution of the Metabolic Research Unit. He has authored more than 75 academic publications and is named as an inventor on more than 40 patent applications. Professor Walder has worked closely with a number of industry partners, and is focused on conducting applied research with tangible outcomes that benefit Australia. In 2014, a compound discovered in Professor Walder’s laboratory successfully completed a Phase 2 clinical trial for the treatment of type 2 diabetes.

Read more on Ken's profile

Career highlights

A new drug for diabetes discovered in Prof Walder's laboratory successfully completed a phase 2 clinical trial, where it caused a significant reduction in plasma HbA1c levels (Simpson et al. Diabetes Care, 2014).

Research interests

Professor Walders research is primarily focused on the discovery and validation of novel drug treatments for complex diseases. This research utilises state of the art equipment and technologies, in combination with unique model systems and sample collections, to screen for small molecules that can be used to treat complex diseases. The novel drug candidates are tested in in vitro and in vivo model systems to establish their potential for development as therapeutics.

Affiliations

European Association for the Study of Diabetes

American Diabetes Association

Australian Diabetes Society

International Association for the Study of Obesity

North American Association for the Study of Obesity

Australian Society for the Study of Obesity

Teaching interests

5 PhD students

Medical Innovations component of HBS400 (Honours)

Units taught

HBS400 (Medical Innovations)

Knowledge areas

Metabolic diseases (obesity, type 2 diabetes, non-alcoholic fatty liver disease).

Mental health (depression, bipolar disorder, schizophrenia).

Genetics.

Drug discovery.

Conferences

Invited presentations at national and international conferences including:

Australian Diabetes Society Annual Scientific Meeting, Sydney, August 2013. Invited seminar presentation: “VVP808 and fatty liver disease”.


Baker-IDI Research Institute Seminar Series, Melbourne, October 2011. Invited seminar presentation: “Use of GES technology to discover a new insulin sensitising agent”.


Frontiers in Obesity Research, Melbourne, September 2011. Invited seminar presentation: “VVP808: A novel insulin sensitising agent”.


University of Melbourne Department of Medicine Seminar Series, Melbourne, May 2010. Invited seminar presentation: “VVP808: A novel insulin sensitising agent”.


Monash University Obesity Diabetes Institute, Melbourne, June 2010. Invited seminar presentation: “Mechanism of action of VVP808”.


MSD Diabetes Meeting, Sydney, October 11-12, 2008. Symposium presentation: “Overview of mitochondrial dysfunction in diabetes”.


GTCbio 3rd Metabolic Diseases World Summit, San Diego, USA, November 1-2, 2007. Symposium presentation: “Use of gene expression signatures to discover novel diabetes therapeutics”.


ASSO 15th Annual Scientific Meeting, Canberra, Australia, August 31-September 2, 2007. Symposium presentation: “The adipocyte as an endocrine organ”.


2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona, Spain, April 25-28, 2007. Symposium presentation: “The mitochondrial protease PARL and type 2 diabetes”.


2nd Scientific Meeting of the Asia-Pacific Diabetes and Obesity Study Group, Kyoto, Japan, August 26-7, 2006. Symposium presentation: “CXS741, A Novel Secreted Protein Involved in the Pathogenesis of Obesity and Type 2 Diabetes”.


1st Scientific Meeting of the Asia-Pacific Diabetes and Obesity Study Group, Kobe, Japan, August 20-1, 2005. Symposium presentation: “Genetic variation in PSARL is associated with plasma insulin concentration”.

Awards

1998 Fogarty Fellowship (NIH)

2006 Smart Geelong Network Biotechnology Researcher of the Year

Projects

Professor Walder serves as a reviewer for the following journals:

Diabetes

Diabetologia

International Journal of Obesity

Molecular and General Genetics

Kidney International

Pancreas



Professor Walder regularly reviews research applications for national and international funding bodies, including NHMRC and ARC.

Publications

Filter by

2016

The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases

Gerwyn Morris, Prof Michael Berk, Piotr Galecki, Prof Ken Walder, Prof Michael Maes

(2016), Vol. 53, pp. 1195-1219, Molecular neurobiology, Berlin, Germany, C1

journal

Citalopram and sertraline exposure compromises embryonic bone development

Mr Daniel Fraher, Dr Jason Hodge, Dr Fiona Collier, Ms Josephine Mcmillan, Richard L. Kennedy, Ms Megan Ellis, Geoff C. Nicholson, Prof Ken Walder, Dr Seetal Dodd, Prof Michael Berk, Prof Julie Pasco, Dr Lana Williams, Dr Yann Gibert

(2016), Vol. 21, pp. 656-664, Molecular psychiatry, London, Eng., C1

journal

Deficiency in apoptosis-inducing factor recapitulates chronic kidney disease via aberrant mitochondrial homeostasis

Melinda T Coughlan, Gavin C. Higgins, Tuong-Vi Nguyen, Sally Penfold, Vicki Thallas Bonke, Sih Min Tan, Georg Ramm, Nicole J. Van Bergen, Darren C. Henstridge, Karly C. Sourris, Dr Brooke Elyse Harcourt, Ian A. Trounce, Portia M. Robb, Adrienne Laskowski, A/Prof Sean Mcgee, Dr Amanda Genders, Prof Ken Walder, Brian G. Drew, Dr Paul Gregorevic, Hongwei Qian, Merlin C. Thomas, George Jerums, Richard J. Macisaac, Alison Skene, David A Power, Elif I. Ekinci, Xiaonan W. Wijeyeratne, Linda A. Gallo, Michal Herman-Edelstein, A/Prof Michael Thomas Ryan, Mark E. Cooper, David R. Thorburn, Josephine M. Forbes

(2016), Vol. 65, pp. 1085-1098, Diabetes, Alexandria, Va., C1

journal

The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmunue disease.

Gerwyn Morris, Prof Michael Berk, Andre F Carvalho, Javier Caso, Yolanda sanz, Prof Ken Walder, Prof Michael Maes

(2016), pp. 1-20, Molecular neurobiology, Berlin, Germany, C1

journal

The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling : new drug targets in neuroimmune disorders

Gerwyn Morris, Prof Ken Walder, Basant Puri, Prof Michael Berk, Prof Michael Maes

(2016), Vol. 53, pp. 4638-4658, Molecular neurobiology, New York, N.Y., C1

journal

Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

Mr Rajneesh Chaudhary, Dr Kislay Roy, Dr Rupinder Kanwar, Prof Ken Walder, Prof Jagat Kanwar

(2016), Vol. 14, pp. 1-17, Journal of nanobiotechnology, London, Eng., C1

journal
2015

Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level.

Lennart Zabeau, Cathy Jensen, Sylvie Seeuws, Koen Venken, Annick Verhee, Dominiek Catteeuw, Geert van Loo, Hui Chen, Prof Ken Walder, Jacob Hollis, Simon Foote, Margaret J Morris, Jose Van der Heyden, Frank Peelman, Brian Oldfield, Justin Rubio, Dirk Elewaut, Jan Tavernier

(2015), Vol. 72, pp. 629-644, Cellular and Molecular Life Sciences, Switzerland, C1

journal

CXCR4 Antagonism attenuates the development of diabetic cardiac fibrosis

Po-Yin Chu, Prof Ken Walder, Duncan Horlock, Dr David Williams, Erin Nelson, Melissa Byrne, Karin Jandeleit-Dahm, Prof Paul Zimmet, David Kaye

(2015), Vol. 10, pp. 1-13, PLoS One, San Francisco, CA, C1

journal

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

Gerwyn Morris, Prof Michael Berk, Prof Ken Walder, Prof Michael Maes

(2015), Vol. 13, pp. 1-23, BMC Medicine, London, Eng., C1

journal

Evolution of optogenetic microdevices

Mr Rajas Kale, Prof Abbas Kouzani, Prof Ken Walder, Prof Michael Berk, Dr Susannah Tye

(2015), Vol. 2, pp. 1-11, Neurophotonics, Bellingham, W.A., C1

journal

The putative role of viruses, bacteria, and chronic fungal biotoxin exposure in the genesis of intractable fatigue accompanied by cognitive and physical disability

Gerwyn Morris, Prof Michael Berk, Prof Ken Walder, Prof Michael Maes

(2015), Vol. In press, pp. 1-22, Molecular neurobiology, Clifton, N.J., C1

journal

Prevalence of beak and feather disease virus in wild Platycercus elegans: comparison of three tissue types using a probe-based real-time qPCR test

Mr Justin Eastwood, Dr Mathew Berg, Prof Kate Buchanan, Prof Ken Walder

(2015), Vol. 63, pp. 1-8, Australian journal of zoology, Clayton, Vic., C1

journal

Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy

Mr Edward Patrick Callaly, Prof Ken Walder, Gerwyn Morris, Prof Michael Maes, Monojit Debnath, Prof Michael Berk

(2015), Vol. 15, pp. 355-365, Mini-reviews in medicinal chemistry, Amsterdam, The Netherlands, C1

journal

Lipid abundance in zebrafish embryos is regulated by complementary actions of the endocannabinoid system and retinoic acid pathway

Mr Daniel Fraher, Ms Megan Ellis, Ms Shona Morrison, A/Prof Sean Mcgee, Prof Alister Ward, Prof Ken Walder, Dr Yann Gibert

(2015), Vol. 156, pp. 3596-3609, Endocrinology, Bethesda, Md., C1

journal

Wireless optogenetics: an exploration of portable microdevices for small animal photostimulation

Mr Rajas Kale, Prof Abbas Kouzani, Prof Michael Berk, Prof Ken Walder, Julian Berk, Dr Susannah Tye

(2015), Vol. 20, pp. 225-230, Procedia technology, Amsterdam, The Netherlands, C1

journal
2014

Non-referenced genome assembly from epigenomic short-read data

Antony Kaspi, Mark Ziemann, Samuel T Keating, Ishant Khurana, Mr Timothy Connor, Ms Briana Spolding, Mr Adrian Cooper, Ross Lazarus, Prof Ken Walder, Prof Paul Zimmet, A/Prof Assam El-Osta

(2014), Vol. 9, pp. 1329-1338, Epigenetics, New York, United States, C1

journal

Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study

Richard J. Simpson, Prof Geoffrey Nicholson, Joseph Proietto, Ms Alana Sarah, Kerrie Margaret Sanders, Gabrielle Phillips, Jo Chambers, Dr Rob Macginley, Capr Neil Orford, Prof Ken Walder, Dr Guy Krippner, Kathy Skoff, Vincent J. Wacher

(2014), Vol. 37, pp. 3121-3123, Diabetes Care, Alexandria VA., C1

journal

Genetic variation associated with hypersensitivity to mercury.

A/Prof David Austin, Ms Briana Spolding, Shakuntla Gondalia, Kerrie A. Shandley, Enzo A. Palombo, Simon R. Knowles, Prof Ken Walder

(2014), Vol. 21, pp. 236-241, Toxicology International, India, C1-1

journal
2013

Genetic basis for the increased expression of vacuolar H+ translocating ATPase genes upon imatinib treatment in human lymphoblastoid cells

Hemant Kulkarni, Harald H. H. Goring, Joanne Curran, Vincent Diego, Thomas D Dyer, Shelley A. Cole, Prof Ken Walder, Prof Gregory Collier, John Blangero, Melanie A. Carless

(2013), Vol. 71, pp. 1095-1100, Cancer chemotherapy and pharmacology, Heidelberg, Germany, C1

journal

Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels

Mr Adam Walker, Sandy A Burnett, Ms Kyoko Hasebe, Prof Jane McGillivray, Dr Laura Gray, A/Prof Sean Mcgee, Prof Ken Walder, Prof Michael Berk, Dr Susannah Tye

(2013), Vol. 242, pp. 76-83, Behavioural brain research, Amsterdam, The Netherlands, C1

journal
2012

The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes

Dr Kristy Bolton, Dr David Segal, Prof Ken Walder

(2012), Vol. 6, pp. 67-72, Biologics : targets and therapy, Auckland, New Zealand, C1

journal

Association of differential gene expression with imatinib mesylate and omacetaxine mepesuccinate toxicity in lymphoblastoid cell lines

Hemant Kulkarni, Harald H. H. Goring, Vincent Diego, Shelley A. Cole, Prof Ken Walder, Prof Gregory Collier, John Blangero, Melanie A. Carless

(2012), Vol. 5, pp. 1-12, BMC medical genomics, London, England, C1

journal

Genetic variation in SH3-domain GRB2-like (endophilin)-interacting protein 1 has a major impact on fat mass

Nicola K. Cummings, Kate Shields, Joanne Curran, Dr Kiymet Bozaoglu, James Trevaskis, Kristi Gluschenko, Guowen Cai, Anthony G. Comuzzie, Thomas D Dyer, Prof Ken Walder, Prof Paul Zimmet, Prof Gregory Collier, John Blangero, Dr Jeremy Jowett

(2012), Vol. 36, pp. 201-206, International journal of obesity, London, England, C1

journal
2011

A head mountable deep brain stimulation device for laboratory animals

Prof Abbas Kouzani, Dr Susannah Tye, Prof Ken Walder, Prof Lingxue Kong

(2011), pp. 275-280, Advances in computer, communication, control and automation, Berlin, Germany, B1

chapter

Deficiency in interferon-y results in reduced body weight and better glucose tolerance in mice

Nicole Wong, Barbara C. Fam, Gitta R. Cempako, Dr Gregory Steinberg, Prof Ken Walder, Thomas W. Kay, Joe Proietto, S Andrikopoulos

(2011), Vol. 152, pp. 3690-3699, Endocrinology, Chevy Chase, Md., C1

journal
2010

Regulation of skeletal muscle oxidative capacity and insulin signaling by the Mitochondrial Rhomboid Protease PARL

Mr Anthony Civitarese, Paul S. MacLean, Stacy Carling, Ms Lyndal Bayles, Ryan P. McMillan, Anson Pierce, Thomas C. Becker, Cedric Moro, Jean Finlayson, Natalie Lefort, Christopher B. Newgard, L Mandarino, William Cefalu, Prof Ken Walder, Prof Gregory Collier, Matthew W. Hulver, Mr Steven Smith, Eric Ravussin

(2010), Vol. 11, pp. 412-426, Cell metabolism, Cambridge, Mass., C1

journal

Effects of rosiglitazone on intramyocellular lipid accumulation in Psammomys obesus

Dr Juan Carlos Molero-Navajas, Mr Scott Lee, Ilit Leizerman, Ayelet Chajut, Mr Adrian Cooper, Prof Ken Walder

(2010), Vol. 1802, pp. 235-239, B B A - Molecular Basis of Disease, Amsterdam, The Netherlands, C1

journal

Genetic variation in PARL influences mitochondrian content

Joanne Curran, Dr Jeremy Jowett, Lawrence J. Abraham, Luke A Diepeveen, Kate Elliott, Thomas D Dyer, Ms Lyndal Bayles, Matthew P Johnson, Anthony G. Comuzzie, Eric K Moses, Prof Ken Walder, Prof Gregory Collier, John Blangero, Dr Ahmed Kissebah

(2010), Vol. 127, pp. 183-190, Human genetics, Heidelberg, Germany, C1

journal
2009

Enhanced proliferation of human skeletal muscle precursor cells derived from elderly donors cultured in estimated physiological (5%) oxygen

Miss Sheree Martin, Dr Fiona Collier, A/Prof Mark Kirkland, Prof Ken Walder, Dr Nicole Stupka

(2009), Vol. 61, pp. 93-107, Cytotechnology: international journal of cell culture and biotechnology, Dordrecht, Netherlands, C1

journal

RTKN2 induces NF-KappaB dependent resistance to intrinsic apoptosis in HEK cells and REgulates BCL-2 genes in human CD4+ lymphocytes

Dr Fiona Collier, Andrea Loving, Adele J. Baker, Janet McLeod, Prof Ken Walder, A/Prof Mark Kirkland

(2009), Vol. 2, pp. 9-23, Journal of cell death, Auckland, New Zealand, C1

journal

Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population

Dr Kiymet Bozaoglu, Dr David Segal, Kate Shields, Nicola K. Cummings, Joanne Curran, Anthony G. Comuzzie, Michael C. Mahaney, David L. Rainwater, John L. Vandenberg, Jean W. MacCluer, Prof Gregory Collier, John Blangero, Prof Ken Walder, Dr Jeremy Jowett

(2009), Vol. 94, pp. 3085-3088, The Journal of Clinical Endocrinology & Metabolism, Philadelphia, PA, C1

journal
2007

Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells

Dr Yuan Gao, Ms Joanne Pagnon, Helen Feng, Dr Nicky Konstantopoulos, Dr Jeremy Jowett, Prof Ken Walder

(2007), Vol. 356, pp. 636-641, Biochemical and biophysical research communications, Orlando, Fla., C1

journal

Localization and expression of selenoprotein S in the testis of Psammomys obesus

Dr Kelly Windmill, Dr Janette Tenne-Brown, Dr Richard Bayles, James Trevaskis, Dr Yuan Gao, Prof Ken Walder

(2007), Vol. 38, pp. 97-101, Journal of molecular histology, Amsterdam, The Netherlands, C1

journal

SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis

Kee-Hong Kim, Dr Yuan Gao, Prof Ken Walder, Prof Gregory Collier, Joseph Skelton, Dr Ahmed Kissebah

(2007), Vol. 354, pp. 127-132, Biochemical and biophysical research communications, Orlando, Fla., C1

journal
2006

Association of genetic vatiation within UBL5 with phenotypes of metabolic syndrome

Dr Kiymet Bozaoglu, Joanne Curran, Kate Elliott, Prof Ken Walder, Thomas D Dyer, David L. Rainwater, John L. Vandenberg, Anthony G. Comuzzie, Prof Gregory Collier, Prof Paul Zimmet, Jean W. MacCluer, Dr Jeremy Jowett, John Blangero

(2006), Vol. 78, pp. 147-159, Human biology, Detroit, Mich., C1

journal
2005

Genetic variation in selenoprotein S influences inflammatory response

Joanne Curran, Dr Jeremy Jowett, Kate Elliott, Dr Yuan Gao, Kristi Gluschenko, Jiajun Wang, Dalia M Abel Azim, Guowen Cai, Michael C. Mahaney, Anthony G. Comuzzie, Thomas D Dyer, Prof Ken Walder, Prof Paul Zimmet, Jean W. MacCluer, Prof Gregory Collier, Dr Ahmed Kissebah, John Blangero

(2005), Vol. 37, pp. 1234-1241, Nature, New York, N.Y., C1-1

journal

PGC-1α gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle

Robert J. Southgate, Dr Clinton Bruce, Andrew L. Carey, Dr Gregory Steinberg, Prof Ken Walder, Robert Monks, Mr Matthew Watt, John A. Hawley, Morris J. Birnbaum, Prof Mark Febbraio

(2005), Vol. 19, pp. 2072-2074, The FASEB journal : official publication of the Federation of American Societies for experimental biology, Bethesda, Md., C1-1

journal

Src homology 3-domain growth factor receptor-bound 2-like (endophilin) interacting protein 1, a novel neuronal protein that regulates energy balance

James Trevaskis, Prof Ken Walder, Dr Torie Foletta, Ms Lyndal Bayles, Dr Janine Mc Millan, Mr Adrian Cooper

(2005), Vol. 146, pp. 3757-3764, Endocrinology, Philadelphia, Pa., C1-1

journal
2004

c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action

Dr Juan Carlos Molero-Navajas, Thomas E Jensen, Phil C Withers, Michelle Couzens, Herbert Herzog, Christine B. F. Thien, Wallace Y. Langdon, Prof Ken Walder, Maria A. Murphy, David D.L. Bowtell, Prof David E James, Gregory Cooney

(2004), Vol. 114, pp. 1326-1333, Journal of clinical investigation, New York, N.Y., C1

journal

Identification and characterization of a lymphocytic Rho-GTPase effector: rhotekin-2

Dr Fiona Collier, Tamara Gough, Courtney Talbot, Prof Ken Walder, A/Prof Mark Kirkland

(2004), Vol. 324, pp. 1360-1369, Biochemical and biophysical research communications, San Diego, Calif., C1

journal

Genetic variation in BEACON influences quantitative variation in metabolic syndrome-related phenotypes

Dr Jeremy Jowett, Kate Elliott, Joanne Curran, Nicola Hunt, Prof Ken Walder, Prof Gregory Collier, Prof Paul Zimmet, John Blangero

(2004), Vol. 53, pp. 2467-2472, Diabetes, Alexandria, Va., C1

journal
2003

ORP3 splice variants and their expression in human tissues and hematopoietic cells

Dr Fiona Collier, J Apostolopoulos, Prof Ken Walder, A/Prof Mark Kirkland

(2003), Vol. 22, pp. 1-9, DNA and cell biology, New Rochelle, N.Y., C1-1

journal

Genetic studies in Psammomys obesus

Prof Ken Walder, Dr David Segal, Dr Jeremy Jowett, John Blangero, Prof Paul Zimmet, Prof Gregory Collier

(2003), Vol. 9, pp. 275-278, Progress in obesity research, Eastleigh, England, C1

journal

Obesity and diabetes gene discovery approaches

Prof Ken Walder, Dr David Segal, Dr Jeremy Jowett, John Blangero, Prof Gregory Collier

(2003), Vol. 9, pp. 1357-1372, Current pharmaceutical design, Schiphol, Netherlands, C1

journal

The taq IA and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesity

Adam G Southon, Prof Ken Walder, Dr Andrea Sanigorski, Prof Paul Zimmet, Prof Geoffrey Nicholson, A/Prof Mark Kotowicz, Prof Gregory Collier

(2003), Vol. 16, pp. 72-76, Diabetes, nutrition & metabolism, Milano, Italy, C1

journal
2002

Elevated hypothalamic beacon gene expression in Psammomys obesus prone to develop obesity and type 2 diabetes

Prof Ken Walder, E Ziv, R Kalman, K. Whitecross, E Shafrir, Prof Paul Zimmet, Prof Gregory Collier

(2002), Vol. 26, pp. 605-609, International journal of obesity, London, England, C1

journal
2001

Genetic variation and obesity in Australian women: A prospective study.

Dr Andrea Sanigorski, Prof Ken Walder, E J Boyko, K. Whitecross, Prof Geoffrey Nicholson, M. Kolowitz, Jon Mark Pascoe, Prof Gregory Collier

(2001), Vol. 9, pp. 733-740, Obesity, Silver Spring, Md., C1

journal

Effects of beacon administration on energy expenditure and substrate utilisation in Psammomys obesus (Israeli sand rats)

Prof Ken Walder, Prof Paul Zimmet

(2001), Vol. 25, pp. 1281-1285, International journal of obesity, London, England, C1

journal
1997

The effect of dietary energy restriction on body weight gain and the development of noninsulin-dependent diabetes mellitus (NIDDM) in Psammomys obesus

Prof Ken Walder, Prof Paul Zimmet

(1997), Vol. 5, pp. 193-200, Obesity research, London, England, C1-1

journal